Key Events This Week
25 May: Golden Cross formation signals potential bullish breakout
26 May: Technical momentum shifts to bullish amid mixed indicators
29 May: Intraday high with 7.1% surge to Rs.287.5
Weekly Close: Rs.279.35, +5.02% vs Sensex +0.01%

Suven Life Sciences Ltd is Rated Sell
2026-05-30 10:10:04Suven Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 May 2026, providing investors with the most up-to-date view of the company's performance and outlook.
Read full news article
Suven Life Sciences Ltd Surges 7.1% to Day's High of Rs 287.5 — Outperforms Sector by 6.39 Percentage Points
2026-05-29 10:32:08The Sensex edged up a modest 0.11% on 29 May 2026, while Suven Life Sciences Ltd surged 7.1%, touching an intraday high of Rs 287.5. This 6.39 percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally rather than a broad market lift.
Read full news article
Suven Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators
2026-05-26 08:03:35Suven Life Sciences Ltd, a small-cap player in the Healthcare Services sector, has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock has delivered impressive returns year-to-date, outperforming the broader Sensex by a wide margin.
Read full news article
Golden Cross Confirmed: Do Suven Life Sciences Ltd's Other Technical Indicators Agree?
2026-05-25 18:00:21The 50-day moving average has crossed above the 200-day moving average for Suven Life Sciences Ltd, signalling a golden cross on 25 May 2026. Yet, the broader technical picture presents a nuanced view, with weekly and monthly indicators diverging and recent price momentum showing mixed signals.
Read full news article









